Psychosocial and productivity impact of caring for a child with peanut allergy.

Caregiver Health-related quality of life Parental burden Peanut allergy Productivity Psychosocial burden

Journal

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313

Informations de publication

Date de publication:
2020
Historique:
received: 13 05 2020
accepted: 29 08 2020
entrez: 28 9 2020
pubmed: 29 9 2020
medline: 29 9 2020
Statut: epublish

Résumé

Limited previous research has assessed the psychosocial burden and productivity impact of caring for a child with peanut allergy and factors associated with burden. The objective of this research was to explore caregiver burden in terms of psychosocial and productivity impact of caring for a child with peanut allergy, the influence of caregiver and child gender on caregiver burden, and factors predicting caregiver burden in peanut allergy. A cross-sectional survey of caregivers of children with peanut allergy was conducted in the United Kingdom, and included sociodemographic and clinical questions, EQ-5D, Hospital Anxiety and Depression Scale, Food Allergy Quality of Life-Parental Burden, Food Allergy Independent Measure, and productivity questions. One hundred caregivers (55% female) of children with peanut allergy (aged 4-15 years) completed the survey. Male and female caregivers reported mean levels of anxiety significantly higher than United Kingdom population norms. Caregivers of children with severe peanut allergy reported significant impacts on their careers and health-related quality of life. Neither caregiver nor child gender impacted burden, indicating that male and female caregivers are equally anxious and suffer the same level of negative career, productivity, and health-related quality-of-life impact due to their child's peanut allergy. Caregivers' perceived risk of outcomes related to their child's peanut allergy (e.g., death or severe reaction) as measured by the Food Allergy Independent Measure independently predicted burden. Caregivers of children with peanut allergy in the United Kingdom experience health-related quality-of-life, psychosocial, and productivity burden; this study demonstrates the high levels of anxiety reported by both male and female caregivers.

Sections du résumé

BACKGROUND BACKGROUND
Limited previous research has assessed the psychosocial burden and productivity impact of caring for a child with peanut allergy and factors associated with burden. The objective of this research was to explore caregiver burden in terms of psychosocial and productivity impact of caring for a child with peanut allergy, the influence of caregiver and child gender on caregiver burden, and factors predicting caregiver burden in peanut allergy.
METHODS METHODS
A cross-sectional survey of caregivers of children with peanut allergy was conducted in the United Kingdom, and included sociodemographic and clinical questions, EQ-5D, Hospital Anxiety and Depression Scale, Food Allergy Quality of Life-Parental Burden, Food Allergy Independent Measure, and productivity questions.
RESULTS RESULTS
One hundred caregivers (55% female) of children with peanut allergy (aged 4-15 years) completed the survey. Male and female caregivers reported mean levels of anxiety significantly higher than United Kingdom population norms. Caregivers of children with severe peanut allergy reported significant impacts on their careers and health-related quality of life. Neither caregiver nor child gender impacted burden, indicating that male and female caregivers are equally anxious and suffer the same level of negative career, productivity, and health-related quality-of-life impact due to their child's peanut allergy. Caregivers' perceived risk of outcomes related to their child's peanut allergy (e.g., death or severe reaction) as measured by the Food Allergy Independent Measure independently predicted burden.
CONCLUSIONS CONCLUSIONS
Caregivers of children with peanut allergy in the United Kingdom experience health-related quality-of-life, psychosocial, and productivity burden; this study demonstrates the high levels of anxiety reported by both male and female caregivers.

Identifiants

pubmed: 32983241
doi: 10.1186/s13223-020-00477-3
pii: 477
pmc: PMC7517656
doi:

Types de publication

Journal Article

Langues

eng

Pagination

83

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsSA and KG are employees of Acaster Lloyd Consulting Ltd. Acaster Lloyd Consulting Ltd was paid by Aimmune Therapeutics to conduct this study. JdV is a consultant for Aimmune Therapeutics. AV and RR are employees of Aimmune Therapeutics. AM is a former employee of Aimmune Therapeutics. RK is a consultant for Aimmune Therapeutics.

Références

JAMA Pediatr. 2013 Nov;167(11):1026-31
pubmed: 24042236
J Pediatr Psychol. 2017 Mar 01;42(2):186-197
pubmed: 27424484
J Allergy Clin Immunol. 2004 Nov;114(5):1159-63
pubmed: 15536425
Qual Life Res. 2015 Feb;24(2):391-8
pubmed: 25064207
Allergy. 2014 Aug;69(8):992-1007
pubmed: 24816523
Clin Exp Allergy. 2000 Aug;30(8):1135-43
pubmed: 10931121
Pediatr Allergy Immunol. 2016 Aug;27(5):459-64
pubmed: 27019307
Allergy. 2010 Jan;65(1):103-8
pubmed: 20078504
Ann Allergy Asthma Immunol. 2001 Dec;87(6):461-4
pubmed: 11770692
J Paediatr Child Health. 2015 Jul;51(7):696-8
pubmed: 25594910
Qual Life Res. 2013 Sep;22(7):1841-9
pubmed: 23076799
J Psychosom Res. 2018 Jan;104:48-54
pubmed: 29275785
J Allergy Clin Immunol. 2011 Mar;127(3):623-30.e1
pubmed: 21236479
Qual Life Res. 2015 Jun;24(6):1369-78
pubmed: 25394894
Ann Allergy Asthma Immunol. 2015 Feb;114(2):117-25
pubmed: 25492096
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Ann Allergy Asthma Immunol. 2014 Jul;113(1):69-74.e2
pubmed: 24950845
Asian Pac J Allergy Immunol. 2018 Mar;36(1):22-26
pubmed: 28802031
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
J Allergy (Cairo). 2016;2016:4850940
pubmed: 27688785
Clin Pediatr (Phila). 2011 Nov;50(11):1045-51
pubmed: 21685213
Allergy. 2010 May;65(5):630-5
pubmed: 19845570
J Allergy (Cairo). 2016;2016:1497375
pubmed: 27429624
J Clin Nurs. 2017 Nov;26(21-22):3371-3381
pubmed: 28000310
Allergy. 2009 Mar;64(3):461-8
pubmed: 19076542
Ann Allergy Asthma Immunol. 2015 Apr;114(4):312-318.e2
pubmed: 25660416
Appetite. 2011 Oct;57(2):467-74
pubmed: 21708202
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
Pediatr Allergy Immunol. 2013 Dec;24(8):798-803
pubmed: 24329879

Auteurs

Sarah Acaster (S)

Acaster Lloyd Consulting Ltd, 16 Woburn Pl, Bloomsbury, London, WC1H 0BS UK.

Katy Gallop (K)

Acaster Lloyd Consulting Ltd, 16 Woburn Pl, Bloomsbury, London, WC1H 0BS UK.

Jane de Vries (J)

Independent Consultant to Aimmune Therapeutics, London, UK.
Aimmune Therapeutics, 10 Eastbourne Terrace, London, W2 6LG UK.

Anne Marciniak (A)

Aimmune Therapeutics, 10 Eastbourne Terrace, London, W2 6LG UK.

Robert Ryan (R)

Aimmune Therapeutics, 10 Eastbourne Terrace, London, W2 6LG UK.

Andrea Vereda (A)

Aimmune Therapeutics, 10 Eastbourne Terrace, London, W2 6LG UK.

Rebecca Knibb (R)

Department of Psychology, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET UK.

Classifications MeSH